Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make timely decisions in the stock market.
Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.
STZ
$142.59+Infinity%1D
Analyst Views on STZ
Wall Street analysts forecast STZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STZ is 167.40 USD with a low forecast of 123.00 USD and a high forecast of 215.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
21 Analyst Rating
Wall Street analysts forecast STZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for STZ is 167.40 USD with a low forecast of 123.00 USD and a high forecast of 215.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
8 Hold
2 Sell
Moderate Buy
Current: 143.470
Low
123.00
Averages
167.40
High
215.00
Current: 143.470
Low
123.00
Averages
167.40
High
215.00
Deutsche Bank
Hold
maintain
$156 -> $160
2025-12-15
New
Reason
Deutsche Bank
Price Target
$156 -> $160
2025-12-15
New
maintain
Hold
Reason
Deutsche Bank raised the firm's price target on Constellation Brands to $160 from $156 and keeps a Hold rating on the shares ahead of the fiscal Q3 report.
Piper Sandler
Michael Lavery
Neutral
downgrade
$155 -> $135
2025-11-21
Reason
Piper Sandler
Michael Lavery
Price Target
$155 -> $135
2025-11-21
downgrade
Neutral
Reason
Piper Sandler analyst Michael Lavery lowered the firm's price target on Constellation Brands (STZ) to $135 from $155 and keeps a Neutral rating on the shares. The firm says it is updating its models and price targets for recently announced GLP-1 news, higher ABV headwinds, as well as tariff relief and other company specific updates. President Trump recently announced deals with Eli Lilly (LLY) and Novo Nordisk (NVO) to cut GLP-1 drug prices for Medicare and Medicaid beneficiaries in 2026 and offer the treatments directly to consumers at a discount on TrumpRX. Faster user uptake growth in the US appears directionally clear, and Piper now estimates about 20% of the U.S. population could be users by 2028.
Citi
Neutral
downgrade
$155 -> $145
2025-09-23
Reason
Citi
Price Target
$155 -> $145
2025-09-23
downgrade
Neutral
Reason
Citi lowered the firm's price target on Constellation Brands to $145 from $155 and keeps a Neutral rating on the shares ahead of the fiscal Q4 report on October 6. The firm cites scanner data weakness and potential margin risk for the target cut.
Barclays
Overweight -> Equal Weight
downgrade
$202 -> $150
2025-09-12
Reason
Barclays
Price Target
$202 -> $150
2025-09-12
downgrade
Overweight -> Equal Weight
Reason
Barclays downgraded Constellation Brands to Equal Weight from Overweight with a price target of $150, down from $202. The firm believes beer category trends and investor sentiment "are likely to be weighed down for some time." The firm is challenged to find a near-term catalyst for beer trends and downgraded Constellation as a result.
About STZ
Constellation Brands, Inc. is a producer and marketer of beer, wine, and spirits with operations in the United States, Mexico, New Zealand, and Italy with brands, such as Corona Extra, Modelo Especial, Robert Mondavi Winery, Kim Crawford, The Prisoner Wine Company, High West, Casa Noble, and Mi CAMPO. Its segments include Beer, Wine and Spirits, and Corporate Operations and Other. In the Beer segment, its portfolio consists of high-end imported beer brands and ABAs. It has a perpetual brand license to produce its Mexican beer portfolio and to import, market, and sell such a portfolio in the United States. In the Wine and Spirits segment, it sells a portfolio that includes higher-end wine brands complemented by certain higher-end spirits brands. Its Corporate Operations and Other segment consists of costs of corporate development, corporate finance, corporate strategy, executive management, growth, human resources, internal audit, investor relations, IT, legal and public relations.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
